Home
Scholarly Works
Key baseline disease characteristics in nAMD are...
Conference

Key baseline disease characteristics in nAMD are not linked to treatment interval extension of aflibercept 8 mg: A post -hoc 96-week PULSAR analysis

Authors

Garweg JG; Lanzetta P; Chaudhary V; Leal S; Machewitz T; Zhang X

Volume

65

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Publication Date

June 1, 2024

Name of conference

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)

Conference place

WA, Seattle

Conference start date

May 5, 2024

Conference end date

May 9, 2024

Conference proceedings

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Issue

7

ISSN

0146-0404

Labels

Fields of Research (FoR)

Contact the Experts team